https://www.gosh.nhs.uk/our-research/our-research-infrastructure/nihr-great-ormond-street-hospital-brc/brc-news/?page=50

Filter by:

Biomedical Research Centre news

Cannabidiol reduces seizures for children with complex epilepsies

14 Jun 2018, 8:49 p.m.

Cannabidiol, a drug derived from cannabis but with the psychoactive ingredients removed, has been shown to reduce seizures by around 40 % in children with a rare form of drug resistant epilepsy known as Lennox-Gastaut syndrome (LGS).

£1 million award to develop gene therapy for rare blood disorder FHL-2

12 Jun 2018, 9:31 a.m.

Professor Bobby Gaspar is to receive investment of up to £1million from the UCL Technology Fund (UCLTF) to support development of a gene therapy for familial haemophagocytic lymphohistiocytosis (FHL type 2 or ‘FHL-2’) through to a clinical trial.

Marking International Clinical Trials Day at GOSH

28 May 2018, 9:59 p.m.

Earlier this month patients and families at GOSH (Great Ormond Street Hospital) were given the chance to get hands-on with science at our Research Activity Trial and with special lessons in the hospital school.

Ian Simcock - Research Radiographer at GOSH

NIHR Clinical Doctoral Fellowships at GOSH: Class of 2018

15 May 2018, 3:02 p.m.

Three Great Ormond Street Hospital (GOSH) staff members have been awarded National Institute for Health Research (NIHR) Clinical Doctoral Fellowships.

Autolus acquires rights to commercialise novel T-cell therapy developed at GOSH and UCLH

24 Apr 2018, 2:56 p.m.

The biopharmaceutical company Autolus has acquired global rights to develop and commercialize a novel T-cell therapy for the treatment of B-cell lymphomas and leukaemias.